The drug designing tools market is anticipated to expand its roots at a steady CAGR of 8.7% during the forecast period. The market is likely to hold a revenue of US$ 3.1 billion in 2023 while it is anticipated to cross a value of US$ 7.1 billion by 2033.
The research report on the drug designing tools market states that advanced bioinformatics techniques involve unique identification methods that assess if the target is druggable. These advanced analyses have made the process successful as it is easy to analyze the chances of failure this way. Furthermore, the application of discovery studio along with the computer-aided drug design software is making the drug designing procedure smooth and easy.
Any drug design project has now planned stages such as preclinical research, FDA review, and clinical research. This is due to the high demand for new drugs and new viruses keep on surfing up while the government is trying its best to prevent the spread through quick drug designing methods.
With the enhanced graphical interface, power drug design, and protein modeling sequence, the discovery studio software is highly preferred by the end users and research fellows. Through this bioinformatic process, there are different drug-designing tools that are used such as antibodies and immunodetection, protein purification, molecular biology, and cell therapy.
The Increasing demand for drugs due to the rising number of chronic diseases and the geriatric population is fuelling the demand for advanced systems like ligand-based drug design methods.
Drug Designing Tools market analysis further explains that the healthcare, and pharmaceutical drug research budgets have increased since the advent of covid-19. The government wants to tackle this situation and hence the sales of chemical modeling, computer-aided drug design, virtual screening, and bioinformatics tools have been increased.
The role of bioinformatics has increased in drug-designing procedures involving phenomena like data mining, protein structure prediction, and effect forecast.
| Attributes | Details |
|---|---|
| Drug Designing Tools Market CAGR (2023 to 2033) | 8.7% |
| Drug Designing Tools Market Size (2023) | US$ 3.1 billion |
| Drug Designing Tools Market Size (2033) | US$ 7.1 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Short-term Growth (2023 to 2026): The increased application of virtual screening, multi-database, and predictive modeling is transforming the drug designing tools market. Additionally, the spreading number of pharmaceutical companies is also another factor booming the market growth. With this wide range of applications, the market is expected to hold US$ 3.1 billion in 2023 while it is likely to reach US$ 3.98 billion by 2026.
Mid-term Growth (2026 to 2029): Artificial intelligence and machine learning integrating with drug designing software is adding high value to the market dynamic. Moreover, the rising research and development in the healthcare industry are expected to fuel the demand for drug-designing tools. This takes a market value from US$ 3.98 billion in 2026 to a value of US$ 5.11 billion in 2029.
Long-term Growth (2029 to 2033): Demand for drug designing tools has been fuelled by the application of new technologies in drug designing and the growing need for cost- and time-effective solutions. These solutions are expected to garner market growth during this period Thus, the drug designing tools market is anticipated to thrive at a steady CAGR of 8.7% between 2023 and 2033.
Expanding pharmaceutical companies with extensive research and advanced design measures are gaining traction in the market. Furthermore, the cost and time-effective solutions that make the whole process smooth, improved, and effective are garnering market growth.
The strategic alliance between producers, drug-designing manufacturers, and innovative ideas such as ligand drug design applications are flourishing the demand for other drug-designing tools. The increased number of medical emergencies such as virus outbreaks, the geriatric population’s low immunity, and high healthcare budgets have propelled market growth.
The advent of smart designing and research technologies across the vertical is providing great support to the already existing drug designing technology. Alongside this, the demand for medicines over surgeries is expanding the drug-designing tools market.
Principal Consultant
Some of the key restraints for the Drug Designing Tools market are Inadequate and less developed infrastructure facilities. Getting a hold of these technologies has become a huge difficulty due to a lack of experienced researchers and sufficient funding.
Poor technology and the option of alternative medicine are limiting the demand for drug-designing tools.
| Region/Country | Revenue Share % (2022) |
|---|---|
| North America | 37.0% |
| Europe | 29.2% |
| The United States | 17.3% |
| Germany | 5.7% |
| Japan | 4.9% |
Expansion of the Geriatric Population, Increased Cases of Chronic Diseases, and Advanced Drug Research Facilities are propelling the Regional Growth
North America drug designing tools market leads in terms of market share. The region held a market share of 37.0% in 2022. The United States itself held a share of 17.3% in 2022. The growth is attributed to the increased healthcare budget, expanding pharmaceutical research and development facilities, and technological advancements.
The integration of the latest technology such as computer-aided drug design software is expected to transform the market dynamics during the forecast period. Furthermore, the growing awareness of technologies in structure-based drug design is driving market growth in North America.
Government Initiatives along with Technological Advancements for Drug Designing Software Development to Boost Regional Market Outlook
China’s drug designing tools market thrives at a CAGR of 10.10% between 2023 and 2033. Increasing government funding in drug designing software, technological improvements, and an increase in the number of research and development facilities are propelling regional growth.
The application of the latest software like discovery studio in a drug design project is becoming popular with time. It is also expected to fuel market growth. Alongside this, the high involvement of market leaders in promoting drug-designing software is also driving the market expansion of drug-designing solutions in China. While India also thrives at a CAGR of 6.90% between 2023 and 2033.
Integration of Artificial Intelligence & Machine Learning with Computer-Based Drug Designing Software is Revolutionizing the Market Growth
Europe region held a market share of 29.2% in 2022 in the drug designing tools market though the United Kingdom market is expected to thrive at a CAGR of 5.80% between 2023 and 2033. The growth is attributed to the flourishing pharmaceutical industry of the United Kingdom while it goes through technological integration procedures.
The drug-making process has been revolutionized through the advent of artificial intelligence and machine learning.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Category | By Solution |
|---|---|
| Leading Segment | Virtual Screening Tools |
| Market Share (2022) | 36.20% |
| Category | By End User |
|---|---|
| Leading Segment | Pharmaceutical Companies |
| Market Share (2022) | 34.70% |
Based on solution type, the virtual screening tools segment leads as it held a market share of 36.2% in 2022. The easy monitoring, increased consumption through the research and development facilities, and its capability of searching libraries of small molecules fuel its growth. Furthermore, the new structure-based virtual screening (SBVS) and ligand-based VS are trending in the category.
Based on the end-user type, pharmaceutical companies consume a big chunk of the industry as they held a market share of 34.7% in 2022. The growth is mainly owed to better capital generation and extended research and development facilities post-pandemic.
The key players focus on providing an enhanced space that makes the designing process smooth, effective, and flexible. The application of highly advanced tools and software is one strategy that key players follow.
Leading drug-designing system firms are also focusing on developing effective and efficient business methods, which may contribute to the global growth of the drug designing tools market.
How can Drug Designing Tools Manufacturers Providers Scale their Businesses in the Market?
Market players in the drug designing tools market are working on prominent strategies such as:
Market Developments:
In 2023, the market has the potential to garner a valuation of US$ 3.1 billion.
China's market is steadily growing at a CAGR of 10.1%.
The market is anticipated to develop at a CAGR of 8.7% through 2033.
The size of the global market is predicted to be US$ 7.1 billion by 2033.
Due to outdated technology and the readily available availability of complementary and alternative therapies, the demand is hampered.
1. Executive Summary | Drug Designing Tools Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Solution 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Solution, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Solution, 2023 to 2033 5.3.1. Multi Databases 5.3.2. Virtual Screening Tools 5.3.3. Structure Designing/ Building Tools 5.3.4. Predictive Analytics 5.3.5. Model Building Tools 5.3.6. Others 5.4. Y-o-Y Growth Trend Analysis By Solution, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Solution, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Chemical Screening 6.3.2. Docking 6.3.3. Target Prediction 6.3.4. Binding Site Prediction 6.3.5. Energy Minimization 6.3.6. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Pharmaceutical Companies 7.3.2. Biotechnology Companies 7.3.3. Academic and Research Institutes 7.3.4. Contract Research Organizations 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2018 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Solution 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Solution 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Solution 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Solution 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Solution 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Solution 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Solution 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Solution 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Solution 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Solution 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Solution 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Solution 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Solution 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Solution 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Solution 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Solution 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Solution 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Solution 16.4.2.2. By Application 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Solution 16.5.2.2. By Application 16.5.2.3. By End User 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Solution 16.6.2.2. By Application 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Solution 16.7.2.2. By Application 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Solution 16.8.2.2. By Application 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Solution 16.9.2.2. By Application 16.9.2.3. By End User 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Solution 16.10.2.2. By Application 16.10.2.3. By End User 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Solution 16.11.2.2. By Application 16.11.2.3. By End User 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Solution 16.12.2.2. By Application 16.12.2.3. By End User 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Solution 16.13.2.2. By Application 16.13.2.3. By End User 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Solution 16.14.2.2. By Application 16.14.2.3. By End User 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Solution 16.15.2.2. By Application 16.15.2.3. By End User 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Solution 16.16.2.2. By Application 16.16.2.3. By End User 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Solution 16.17.2.2. By Application 16.17.2.3. By End User 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Solution 16.18.2.2. By Application 16.18.2.3. By End User 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Solution 16.19.2.2. By Application 16.19.2.3. By End User 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Solution 16.20.2.2. By Application 16.20.2.3. By End User 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Solution 16.21.2.2. By Application 16.21.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Solution 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Agilent Technologies 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Schrödinger LLC 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Biovia Corporation 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. BioSolveIT GmbH 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. ChemAxon 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Albany Molecular Research Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. OpenEye Scientific Software Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. XtalPi Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Novo Informatics 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Perkinelmer 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Drug Designing Tools Market
